Surgery Partners, Inc. (SGRY) Tops Q3 EPS by 5c; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts SGRY Hot Sheet
Join SI Premium – FREE
Surgery Partners, Inc. (NASDAQ: SGRY) reported Q3 EPS of $0.19, $0.05 better than the analyst estimate of $0.14. Revenue for the quarter came in at $674.1 million versus the consensus estimate of $671.99 million.
GUIDANCE:
Surgery Partners, Inc. sees FY2023 revenue of $2.75 billion, versus the consensus of $2.76 billion.
For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- MaxLinear (MXL) Tops Q3 EPS by 6c; Offers Outlook
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
